AIA
BSX icon

Aventus Investment Advisors’s Boston Scientific BSX Stock Holding History

Aventus Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.1K Sell
1,737
-466
-21% -$25.3K 0.05% 46
2026
Q1 		$138K Buy
2,203
+367
+20% +$29.4K 0.12% 41
2025
Q4 		$175K Buy
1,836
+99
+6% +$9.71K 0.14% 38
2025
Q3 		$170K Hold
1,737
– – 0.14% 39
2025
Q2 		$187K Buy
+1,737
New +$176K 0.17% 38

Other funds holding BSX

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
YIH
Y-Intercept (HK) Hong Kong $5.05B AUM 17.89% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return

Aventus Investment Advisors's BSX Position: Q2 2026 in Review

Aventus Investment Advisors reduced its Boston Scientific (BSX) stake by 21% in Q2 2026, selling an estimated $25.3K and leaving 1,737 shares worth $74.1K. The position accounts for 0.05% of the portfolio, ranked #46.

Aventus Investment Advisors first reported a position in BSX in Q2 2025 and has held it in 5 quarters since. The position peaked at $187K in Q2 2025. 376 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Aventus Investment Advisors held 1,737 shares of Boston Scientific worth $74.1K as of Q2 2026.
  • Aventus Investment Advisors sold 466 Boston Scientific shares in Q2 2026, an estimated $25.3K.
  • Boston Scientific made up 0.05% of Aventus Investment Advisors's portfolio in Q2 2026, its #46 holding.
  • Aventus Investment Advisors first reported a position in Boston Scientific in Q2 2025 and has held it in 5 quarters since.
  • Aventus Investment Advisors's Boston Scientific position peaked at $187K in Q2 2025.
  • 376 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Aventus Investment Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.